Pakistan to start private imports of CanSino vaccine for sale this week

Tariq Butt, Correspondent / Reuters

A private company in Pakistan will begin receiving shipments of China's CanSino Biologics COVID-19 vaccine this week for commercial sale, an official at the company's local partner told Reuters on Monday.

The Drug Regulatory Authority of Pakistan (Drap) has notified a formula for maximum retail prices of COVID-19 vaccines.

A Drap notification said that two formulas have been approved for sale of vaccine with 40 per cent mark-up for companies and additional 15 per cent for retailers/hospitals.

In the meantime, Interior Minister Sheikh Rashid Ahmed got himself vaccinated with SinoPharm's COVID-19 vaccine at a government hospital in Islamabad. He later said that the intensity of the disease was increasing in Pakistan and urged citizens to not delay their vaccinations.

Pakistan, one of the first countries in the world to allow private imports of COVID-19 vaccines, has already received a batch of the Russian Sputnik vaccine for commercial sale.

"We expect the first 10,000 doses to come on March 25, and 100,000 next month and 200,000 the month after," said Hassan Abbas, an official of AJ Pharma, CanSino's local partner, which will be importing the vaccine.

Abbas said the commercial name of the vaccine would be "Convidecia." Five hospitals that took part in clinical trials for the vaccine will be provided the doses for commercial sale, he added.

The first formula for imported vaccines, in finished form, states that the trade price will be equal to landed cost plus 40 per cent mark-up.

According to the second formula, which is for imported vaccines in bulk form and local repack, the trade price will be equal to landed cost plus packaging cost and 40 per cent mark-up for companies. Moreover, retailers/institutions will get 15 per cent of the price as commission.

Pakistan is in the process of vaccinating frontline healthcare workers and citizens over the age of 60 free of charge using Sinopharm doses donated by China.

The commercial administration of vaccines is yet to begin as the government settles pricing issues for the private sector, after reversing its decision to allow uncapped prices.

CanSino Biologics and Pakistan's Health Minister Faisal Sultan did not immediately respond to requests for comment.
Pakistan is in the midst of a sharp rise in COVID-19 infections, and on Saturday reported the highest number of positive cases in day since July last year.